FASN and metabolic dysfunction-associated steatotic liver disease: A previous study demonstrated that increased expression of lipogenic genes including sterol regulatory element binding protein-1 (SREBP1), fatty acid synthase (FASN), and acetyl-CoA carboxylase was observed in NAFLD patients4.